NY Times: Stem Cell Research Funding 'Fairly Robust'...Or Is It?
The blind men and the elephant are doing their dance again. One of the participants in the latest tango is the New York Times. Others include a venture capitalist and stem cell businessmen.
Here is what the Times carried in a July 25 piece by reporter Jodi Rudoren:
"Even with the limitations on federal financing, the overall financing available for stem …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.